The drug, payer and pharmacy benefit manager industries all believe a move toward value-based pay will lower health care costs, but drug-pricing watchdogs disagree. New estimates from an industry coalition predict three changes meant to foster value-based pay would save $48 billion and lower drug prices by 5 percent -- but the pricing watchdogs call those proposals “Pharma’s regulatory rollback shopping list." Also, while there is general consensus about moving toward paying for value, industry stakeholders do not agree on...